TCM
ROIV icon

Teza Capital Management’s Roivant Sciences ROIV Stock Holding History

Teza Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-69,116
Closed -$779K – 259
2025
Q2 		$779K Buy
69,116
+48,804
+240% +$529K 0.58% 35
2025
Q1 		$205K Buy
+20,312
New +$220K 0.09% 363
2024
Q3 		– Sell
-33,240
Closed -$351K – 723
2024
Q2 		$351K Buy
33,240
+1,936
+6% +$21.2K 0.04% 420
2024
Q1 		$330K Buy
+31,304
New +$338K 0.04% 418

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Teza Capital Management's ROIV Position: Q3 2025 in Review

Teza Capital Management sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 69,116 shares — an estimated $779K sold.

Teza Capital Management first reported a position in ROIV in Q1 2024 and held it in 4 quarters. The position peaked at $779K in Q2 2025. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Teza Capital Management reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Teza Capital Management sold 69,116 Roivant Sciences shares in Q3 2025, an estimated $779K.
  • Teza Capital Management first reported a position in Roivant Sciences in Q1 2024 and held it in 4 quarters.
  • Teza Capital Management's Roivant Sciences position peaked at $779K in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Teza Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.